In the ever-evolving healthcare landscape, digital transformation is at the forefront, with telemedicine and artificial intelligence driving unprecedented innovation. These breakthroughs are not just reshaping healthcare delivery but also making it more accessible worldwide. As these pioneering advancements gain momentum, is global healthcare on the brink of transformative breakthroughs that will set new standards for accessibility and quality?
The next big kicker for healthcare business lies in single-speciality hospitals and specialty clinics, from nephrology to IVF, eye-care to dental care, dermatology and more. How does the growth opportunity look for different segments within healthcare?
The Indian diagnostics sector has seen the larger players slowly taking market share from the neighbourhood shops. What is the next frontier for diagnostics firms? Are there newer pathology practice areas on the drawing board or inorganic expansion to go deeper the only way forward?
Traditionally, foreign medtech majors have dominated the length and breadth of medical devices business in India. Despite emergence of few local champions we have a long way to go for creating medtech devices for the vast population with local nuances and conditions. Where are we in the evolution cycle? What more would it take than the National Medical Devices Policy of last year to make it take off?
India has taken advantage of China+1 policy in tapping into the growing global demand for APIs. However, there is a scope for further improvement. What are the to-dos for Indian companies to make a bigger splash in the global API market?
E-pharmacies have become an additional channel to reach to the patients. In a country where a medicine shop is around every nook and corner, how have e-pharmacies scaled up and how can they move up further in the value chain catering to the patient?
Large private investors have struck deals in both multi-speciality and single-speciality hospitals. What are the learnings from past investments in the two sides of the healthcare services arena? Will we see single speciality chains also become part of larger multi-speciality chains in the future?
The "Platform Play" strategy, popular in Western markets, is gaining momentum among private equity firms looking to strengthen their footprint in India. Healthcare sector has been a hotbed of such strategy by PE investors, looking at a buy and build strategy.
However, this strategy is far from easy. It requires careful selection of the right platform company—one with a strong market position, scalable operations, and alignment with potential acquisitions. What factors should PE firms consider when choosing a platform company? How can they navigate the hurdles of executing a successful platform play?
India, with the world’s largest livestock population, faces a growing challenge from animal diseases. This has spurred global pharmaceutical and biotech firms to invest in research and development of new drugs and vaccines. As demand for livestock products increases, India is emerging as a key player in the global animal health market. How can stakeholders overcome challenges like absence of conservation strategy and supply chain inefficiencies to unlock India’s full potential in animal health?
The idea of India as a retirement migration destination is gaining traction. With its diverse landscape and affordable living and healthcare options, the country has the potential to attract retirees globally. That apart, the ageing population domestically also creates a captive market for senior living projects. This surge in demand for eldercare has already prompted investor interest in India’s senior living segment, with ventures in geriatric care securing funding from institutional backers. However, the industry faces challenges such as affordability constraints and societal acceptance, which could slow its momentum. How can the sector innovate to ensure accessibility while scaling effectively?
India’s anti-obesity market is poised for significant expansion, driven by increasing obesity rates and a scarcity of approved treatment options. Currently dominated by the off-label use of diabetes drugs, the market is on the verge of transformation with the anticipated entry of new therapies like Wegovy and Zepbound, alongside domestic biosimilars. These developments are expected to drive intense competition as companies vie to address the weight-loss needs of the world’s third most obese nation—a market projected to surge to $150 billion within the next decade.
How can international and domestic players address the unique challenges of a price-sensitive yet high-demand Indian market? Are Indian drugmakers prepared to compete with global firms in delivering affordable weight-loss solutions?
VCC Events opens up the avenues for participation. Join hands to be a part of India's largest gathering of alternative investments leaders, industry stakeholders and Asia’s influential limited partners, general partners and marquee advisors. Your chance to actively participate and augment yourself as thought leaders.
Dr. Shuchin Bajaj is the Founder Director of Ujala Cygnus Hospitals. Ujala Cygnus is currently operating nineteen hospitals in Delhi, Uttarakhand, Uttar Pradesh, Jammu & Kashmir and Haryana with a combined bed strength of 2000 beds and more than 2500 employees, with a vision to provide superspeciality and emergency healthcare to district towns of the states of India where no such facilities currently exist. It aims to expand to 25 hospitals with a bed strength of 2500 beds by the end of 2025.
Shuchin is a highly qualified medical scholar. After completing his MBBS from PGIMS, Rohtak, he did his Doctorate in Internal Medicines (MD) from Dr S N Medical College, Jodhpur in 2004. Apart from the foregoing, he also did Certified Professional course on Diabetes Management and Total Control from American Academy of Continuing Medical Education, USA in 2008, Advanced Program in Strategic Management from I.I.M. Calcutta in 2013 and Advanced Program in Cardiac Emergencies from Boston University in 2014.
Shuchin is a Senior fellow at the Aspen New Voices Program, Committed to making the voices of the ground level workers and changemakers being heard by the policy makers.
Dr Bajaj was the recipient of the British Government’s 2015 Chevening Gurukul Fellowship for Leadership and Excellence award at King’s College London, where he spent considerable time studying the various facets of Leadership, its various challenges and its learnings for India.
He was also selected for freeship to the ‘Innovating Health for Tomorrow” Fellowship at INSEAD, France in 2017 and his project for Ambulance services was the top of the class of 40 high ranked professionals from around the world.
Shuchin is also an Aspire Fellow, a Fellowship dedicated to enlightened social leadership, held at IIM, Ahmedabad and conducted by Dr. Pradeep Khandwala, Ex Director, IIMA.
He has also completed the Elite Seed Transformation Program conducted by the Stanford Global Business School.
He is on the board of a number of national prominent NGOs as Advisor-Health Programmes and played an active part in the Helpage International’s Regional Research Initiative on Older People’s Health as the Academic partner of the International Health Working Group in 2008, as well as being part of the Healthcare Track for Xynteo’s India2022 coalition.
In addition to numerous other awards and accolades, Shuchin has received the “World Wide Achievers Health Care Excellence Award 2014” for Healthcare Excellence in Internal Medicine in Delhi and NCR, ”Best Consultant in Internal Medicine in Delhi 2012” by the Time Research Media Foundation, “National Award for Excellence in Healthcare 2015” for fastest growing healthcare chain in North India along with “2015 Leaders Award”. In the past Dr. Bajaj has also received “Stars of the Industry Healthcare Awards” for excellence in managing tertiary healthcare centers in Tier-II towns, “4th MT India Healthcare Awards” for most promising healthcare chain of India, Most Promising Healthcare Brand and Best Upcoming Hospital Chain, amongst others. Dr Bajaj and the Cygnus Team were featured by the Economic Times in a feature on Entrepreneurs Leading Disruptive Change. Dr. Bajaj is also the winner the Healthcare Leader of the Year, 2017 Awards.
Shuchin is an avid Healthcare Investor and is associated with multiple Health Tech Companies as investor, Board Member and mentor. He is on the TBIU Board of FITT, IIT, Delhi and was also a member of the Advisory Council to the previous Minister of State for Health, Shri Ashwini Choubey.
Shuchin is also part of the founding team of Medpho, a Digital Health Startup that is committed to providing the highest level of high quality healthcare access to communities that are not part of the mainstream. The startup is already ensuring surgeries to hundreds of patients per month at zero out of pocket expenses.
Over the last two years, Shuchin has been fighting the war on the pandemic as a frontline warrior doing clinical work including Covid ICU duties and managing his nineteen hospitals offering covid care to thousands of patients daily. Shuchin has also been a core team member of Project StepOne, helping 21 state governments manage their Covid response ranging from helplines to home isolation management to plasma management, attending to four million patients in the process, as well as running a free 1000 bed covid hospital with the largest field ICU in the country of 308 beds in Delhi and a 100 bed free Covid Hospital in Prayagraj. Shuchin has also appeared on FM Radio leading multiple campaigns on Covid education, Vaccination, myth busting and plasma donation. He has also been very visible on TV and social media for these efforts. His Facebook profile was blue tick verified recently due to these educational activities.
Adarsh Narahari is the Managing Director of Primus Senior Living, pioneering luxury communities for seniors in India. His entrepreneurial spirit and passion led to the creation of Primus, a brand dedicated to providing affluent, independent seniors with the best living options.
To ensure Primus offers unparalleled senior living experiences, Adarsh travelled extensively, studying the finest global retirement communities. His efforts have earned numerous accolades, including the ET Business Excellence Award for “Excellence in Creating Senior Living Communities” (2020), Times Business Awards for “Best Senior Living Community in Bangalore” (2021) and “Best Senior Citizen Community” (2022).
Under Adarsh’s leadership, Primus has set a new standard for senior living excellence. With over 3,500 senior homes being developed across six South Indian metros, Adarsh aims to promote healthy lifestyles and holistic care for seniors nationwide. His dedication earned him the “Young Entrepreneur of the Year” award in 2018 and 2023 by ET. In 2024 Adarsh got two of the most sought-after investors, General Catalyst and Nikhil Kamat to invest in Primus
Beyond Primus, Adarsh is the managing partner of ReWild Retreats , offering uber-luxurious, nature-based weekend getaways in stunning locations.
Adarsh holds a Master’s degree in Construction Management from the University of Leeds, UK, and a degree in Industrial Engineering and Management from RV College of Engineering, Bangalore. He has served, on the board of Entrepreneurs Organization, Bengaluru, and as the past chairman for ASLI (Association of Senior Living India).
A serial entrepreneur and seasoned executive with over twenty years of senior management and entrepreneurial experience in healthcare and software industries. Has worked in a spectrum of business environments from early stage companies (Clove, Simplexis, Amitive) to mid sized companies (i2, Bain&Co) and large companies (SAP, P&G).
Currently, is the founder and CEO of India's fastest growing chain of high-quality dental clinics. Healthcare in India lags behind WHO world averages and need for deploying good quality infrastructure is critical. Clove began operations in mid 2011 and as of November 2024 had over 550 dental centers offering all aspects of dental care to Indian consumers. Company is adding 90-120 centers every year as the infrastructure deployment tries to catch up to the need that exceeds 2500 new clinics every year (across India).
Also recognized leader in the cloud computing space having built one of the industry's leading and patented software application development platform (Amitive). In late 2010, GXS acquired Amitive's platform and migrated its entire application portfolio onto Amitive's platform.
A change agent with proven experience building products and companies both inside a large company and outside. At SAP, he lead and built SAP's RFID business into one of its fastest growing business units. In addition as SVP of Supply Chain, Product Lifecyle Mgmt. and Manufacturing solutions, managed a team of over 500 professionals and lead one of SAP's product areas globally and helped grow the business. At Simplexis he built a leading public sector procurement technology company. A company he started with some Harvard Business School colleagues and Senator Lamar Alexander who remained chairman of the company until company was sold in 2002.
He enjoys traveling, golf, tennis and spending time with family. He can be reached directly at amar@amarsingh.org
Drop us a line and we will call you.
